About this trial
The main purpose of this study is to investigate genetic, serological, immunological and microbiata diversities between different coeliac disease phenotypes and to discover applicable prognostic markers for specific phenotypes.
Eligibility criteria
Qualifiers
Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis
Cohort 3: friend or non-related family member of coeliac disease or dermatitis herpetiformis patient
Disqualifiers
Cohorts 1-3: Age <18 years
Cohorts 1 and 2: coeliac disease or dermatitis herpetiformis diagnosis not confirmed
Cohort 3: coeliac disease or dermatitis herpetiformis diagnosis
Trial design
Treatments tested in this trial
- Genetic predisposition
Treatment groups
Sponsors and collaborators
Tampere University Hospital
Lead sponsor
Tampere University
Collaborator
University of Helsinki
Collaborator
University of Turku
Collaborator
Oulu University Hospital
Collaborator
University of Debrecen
Collaborator
University of Trieste
Collaborator
Oslo University Hospital
Collaborator